Max Robotics — Global Service Robot Directory + US Certification

About

Samuel So is a leading figure in hepatobiliary and pancreatic surgery, with a distinguished career focused on gastric cancer, liver transplantation, and viral hepatitis. As the founder of the Asian Liver Center at Stanford University, he has been instrumental in advancing the understanding and treatment of hepatitis B and its long-term complications, including hepatocellular carcinoma. His major contributions include pioneering work in living-donor liver transplantation and developing comprehensive strategies for hepatitis B screening and prevention in high-risk populations. So's research has had a profound impact, with his most-cited paper, "A Summary of the 2020 Gastric Cancer Summit at Stanford University," garnering 48 citations and highlighting his leadership in synthesizing global expertise on gastric cancer management. Beyond his clinical and research achievements, he is a passionate advocate for health equity, particularly in underserved Asian and Pacific Islander communities. His work has shaped international guidelines and improved outcomes for patients with liver and gastric cancers, making him a transformative force in surgical oncology and public health.